Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Lexington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Dicerna Pharmaceuticals Inc has filed 657 SEC EDGAR filings since 01 May 2007

SEC filing history

Showing 301-325 of 656 matching filings.

Per page
25
Current page
13
4

FORM 4 SUBMISSION

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36281

8-K

Filing date
04 Jan 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87866

SC 13D

Filing date
20 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Nov 2018
Reporting date
07 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-36281

10-Q/A

Filing date
07 Nov 2018
Reporting date
30 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87866

SC 13D/A

Filing date
07 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
06 Nov 2018
Reporting date
02 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Nov 2018
Reporting date
02 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36281

8-K

Filing date
05 Nov 2018
Reporting date
05 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87866

SCHEDULE 13D/A BY DOMAIN PARTNERS VIII, L.P. FOR DICERNA PHARMACEUTICALS, INC.

Filing date
05 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
05 Nov 2018
Reporting date
30 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87866

SCHEDULE 13D AMENDMENT NO. 6

Filing date
02 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
01 Nov 2018
Reporting date
30 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Nov 2018
Reporting date
30 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36281

FORM 8-K

Filing date
29 Oct 2018
Reporting date
25 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36281

8-K

Filing date
24 Oct 2018
Reporting date
22 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36281

CT ORDER filing

Filing date
13 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36281

8-K

Filing date
11 Sep 2018
Reporting date
06 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-224989

424B5

Filing date
10 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Sep 2018
Reporting date
05 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-224989

424B5

Filing date
06 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .